Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinan Shengqi Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a core subsidiary of the Qilu Pharmaceutical Group. Based in the High-tech Zone of Jinan, the company operates advanced production facilities dedicated to the synthesis of active pharmaceutical ingredients (APIs) and the formulation of finished drugs. Its operations are heavily integrated into Qilu's broader strategy, focusing on the production of high-quality generic versions of complex therapeutics in oncology, cardiology, and infectious diseases. The company holds multiple Good Manufacturing Practice (GMP) certifications from international regulatory bodies, including the US FDA and the EMA. This allows Jinan Shengqi to export its products to various highly regulated international markets, including the United States, Europe, and Japan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinan Shengqi Pharmaceutical.